Literature DB >> 22203332

Screening for the hereditary spastic paraplaegias SPG4 and SPG3A with the multiplex ligation-dependent probe amplification technique in a large population of affected individuals.

Anna Sulek1, Ewelina Elert, Marta Rajkiewicz, Elzbieta Zdzienicka, Iwona Stepniak, Wioletta Krysa, Jacek Zaremba.   

Abstract

Hereditary spastic paraplaegias are a group of clinically and genetically heterogeneous neurodegenerative disorders characterised by progressive spasticity and weakness in the lower limbs. The most common forms of hereditary spastic paraplaegia are SPG4 and SPG3A caused by sequence variants in the SPAST and ATL1 genes, as well as by deletions and duplications not detected by standard techniques. In this study, we used the multiplex ligation-dependent probe amplification (MLPA) analysis for screening 93 patients (52 familial and 41 isolated cases). As a result, we identified 11 different deletions and 1 duplication in the SPAST gene and a single exon deletion in the ATL1 gene. These results indicate that micro-rearrangements in the SPAST gene are a fairly frequent cause of hereditary spastic paraplaegia and that MLPA is a useful and efficient technique to detect a considerable proportion of the mutations in the most common forms of hereditary spastic paraplaegias.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203332     DOI: 10.1007/s10072-011-0899-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  13 in total

1.  Hereditary (familial) spastic paraplegia; further clinical and pathologic observations.

Authors:  G A SCHWARZ; C N LIU
Journal:  AMA Arch Neurol Psychiatry       Date:  1956-02

2.  EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias.

Authors:  T Gasser; J Finsterer; J Baets; C Van Broeckhoven; S Di Donato; B Fontaine; P De Jonghe; A Lossos; T Lynch; C Mariotti; L Schöls; A Spinazzola; Z Szolnoki; S J Tabrizi; C M E Tallaksen; M Zeviani; J-M Burgunder; H F Harbo
Journal:  Eur J Neurol       Date:  2009-12-28       Impact factor: 6.089

3.  Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia.

Authors:  Alexandra Dürr; Agnès Camuzat; Emilie Colin; Chantal Tallaksen; Didier Hannequin; Paula Coutinho; Bertrand Fontaine; Annick Rossi; Roger Gil; Christophe Rousselle; Merle Ruberg; Giovanni Stevanin; Alexis Brice
Journal:  Arch Neurol       Date:  2004-12

4.  Strümpell's familial spastic paraplegia: genetics and neuropathology.

Authors:  W M Behan; M Maia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-01       Impact factor: 10.154

Review 5.  Hereditary spastic paraplegias.

Authors:  A E Harding
Journal:  Semin Neurol       Date:  1993-12       Impact factor: 3.420

6.  High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia.

Authors:  C Beetz; A O H Nygren; J Schickel; M Auer-Grumbach; K Bürk; G Heide; J Kassubek; S Klimpe; T Klopstock; F Kreuz; S Otto; R Schüle; L Schöls; A-D Sperfeld; O W Witte; T Deufel
Journal:  Neurology       Date:  2006-10-11       Impact factor: 9.910

7.  Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia.

Authors:  Christel Depienne; Estelle Fedirko; Sylvie Forlani; Cécile Cazeneuve; Pascale Ribaï; Imed Feki; Chantal Tallaksen; Karine Nguyen; Bruno Stankoff; Merle Ruberg; Giovanni Stevanin; Alexandra Durr; Alexis Brice
Journal:  J Med Genet       Date:  2006-11-10       Impact factor: 6.318

8.  Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia.

Authors:  Moneef Shoukier; Juergen Neesen; Simone M Sauter; Loukas Argyriou; Nadine Doerwald; D V Krishna Pantakani; Ashraf U Mannan
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

9.  An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion.

Authors:  Christian Beetz; Anders O H Nygren; Thomas Deufel; Evan Reid
Journal:  Neurogenetics       Date:  2007-07-27       Impact factor: 3.017

10.  Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia.

Authors:  Victoria Alvarez; Elena Sánchez-Ferrero; Christian Beetz; Marta Díaz; Belén Alonso; Ana I Corao; Josep Gámez; Jesús Esteban; Juan F Gonzalo; Samuel I Pascual-Pascual; Adolfo López de Munain; Germán Moris; Renne Ribacoba; Celedonio Márquez; Jordi Rosell; Rosario Marín; Maria J García-Barcina; Emilia Del Castillo; Carmen Benito; Eliecer Coto
Journal:  BMC Neurol       Date:  2010-10-08       Impact factor: 2.474

View more
  11 in total

1.  The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles.

Authors:  Philip M Boone; Bo Yuan; Ian M Campbell; Jennifer C Scull; Marjorie A Withers; Brett C Baggett; Christine R Beck; Christine J Shaw; Pawel Stankiewicz; Paolo Moretti; Wendy E Goodwin; Nichole Hein; John K Fink; Moon-Woo Seong; Soo Hyun Seo; Sung Sup Park; Izabela D Karbassi; Sat Dev Batish; Andrés Ordóñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanne Stemmler; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-07-24       Impact factor: 11.025

Review 2.  Genotype-phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients.

Authors:  Maryam Erfanian Omidvar; Shahram Torkamandi; Somaye Rezaei; Behnam Alipoor; Mir Davood Omrani; Hossein Darvish; Hamid Ghaedi
Journal:  J Neurol       Date:  2019-11-19       Impact factor: 4.849

3.  SPAST mutation spectrum and familial occurrence among Czech patients with pure hereditary spastic paraplegia.

Authors:  Anna Uhrová Mészárosová; Martina Putzová; Marie Čermáková; Dagmar Vávrová; Kateřina Doležalová; Irena Smetanová; David Stejskal; Christian Beetz; Pavel Seeman
Journal:  J Hum Genet       Date:  2016-06-23       Impact factor: 3.172

4.  The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes.

Authors:  Lorena Travaglini; Chiara Aiello; Fabrizia Stregapede; Adele D'Amico; Viola Alesi; Andrea Ciolfi; Alessandro Bruselles; Michela Catteruccia; Simone Pizzi; Ginevra Zanni; Sara Loddo; Sabina Barresi; Gessica Vasco; Marco Tartaglia; Enrico Bertini; Francesco Nicita
Journal:  Neurogenetics       Date:  2018-04-24       Impact factor: 2.660

5.  Targeted next-generation sequencing improves diagnosis of hereditary spastic paraplegia in Chinese patients.

Authors:  Cong Lu; Li-Xi Li; Hai-Lin Dong; Qiao Wei; Zhi-Jun Liu; Wang Ni; Aaron D Gitler; Zhi-Ying Wu
Journal:  J Mol Med (Berl)       Date:  2018-06-11       Impact factor: 4.599

6.  Mutation analysis of SPAST, ATL1, and REEP1 in Korean Patients with Hereditary Spastic Paraplegia.

Authors:  Tae-Hyoung Kim; Jae-Hyeok Lee; Young-Eun Park; Jin-Hong Shin; Tai-Seung Nam; Hyang-Sook Kim; Ho-Jung Jang; Artem Semenov; Sang Jin Kim; Dae-Seong Kim
Journal:  J Clin Neurol       Date:  2014-07-03       Impact factor: 3.077

7.  Copy number variations in a population-based study of Charcot-Marie-Tooth disease.

Authors:  Helle Høyer; Geir J Braathen; Anette K Eek; Gry B N Nordang; Camilla F Skjelbred; Michael B Russell
Journal:  Biomed Res Int       Date:  2015-01-08       Impact factor: 3.411

8.  Clinical features and genotype-phenotype correlation analysis in patients with ATL1 mutations: A literature reanalysis.

Authors:  Guo-Hua Zhao; Xiao-Min Liu
Journal:  Transl Neurodegener       Date:  2017-04-04       Impact factor: 8.014

9.  Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing.

Authors:  Anke Hensiek; Stephen Kirker; Evan Reid
Journal:  J Neurol       Date:  2014-12-06       Impact factor: 4.849

10.  Mechanistic basis of an epistatic interaction reducing age at onset in hereditary spastic paraplegia.

Authors:  Timothy Newton; Rachel Allison; James R Edgar; Jennifer H Lumb; Catherine E Rodger; Paul T Manna; Tania Rizo; Zacharias Kohl; Anders O H Nygren; Larissa Arning; Rebecca Schüle; Christel Depienne; Lisa Goldberg; Christiane Frahm; Giovanni Stevanin; Alexandra Durr; Ludger Schöls; Beate Winner; Christian Beetz; Evan Reid
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.